A carregar...
Breakthrough venous thromboembolic events in five patients with COVID‐19 on direct oral anticoagulants
WHAT IS KNOWN AND OBJECTIVE: Coronavirus disease 2019 (COVID‐19) is associated with increased risk of venous thromboembolism (VTE). Guidance for VTE prophylaxis continues to evolve, including addressing direct oral anticoagulants (DOACs) continued upon hospitalization. CASE SUMMARIES: We present 5 p...
Na minha lista:
| Publicado no: | J Clin Pharm Ther |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7753371/ https://ncbi.nlm.nih.gov/pubmed/33217032 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcpt.13311 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|